Philippe Brunner

Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [⁹⁰Y-DOTA]-TOC in Metastasized Neuroendocrine Cancers

Anna Imhof, Philippe Brunner, Nicolas Marincek et al. · Journal of Clinical Oncology · 2011 · 621 citations

Medicine, Oncology, Pharmacology +17

Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty.

B. Padovani, O. Kasriel, Philippe Brunner et al. · PubMed · 1999 · 477 citations · Full text

Medicine, Orthopedic Surgery, Surgery +17

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [⁹⁰Y-DOTA]-TOC Versus [⁹⁰Y-DOTA]-TOC Plus [¹⁷⁷Lu-DOTA]-TOC in Neuroendocrine Cancers

Linda Villard, Anna Romer, Nicolas Marincek et al. · Journal of Clinical Oncology · 2012 · 184 citations · Full text

Medicine, Oncology, Pharmacology +16

Somatostatin Receptor–Targeted Radiopeptide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial

Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont et al. · Journal of Nuclear Medicine · 2015 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17

Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry

Daniel Baumhoer, Philippe Brunner, Serenella Eppenberger‐Castori et al. · Oral Oncology · 2013 · 84 citations

Medicine, Maxillofacial Surgery, Surgery +14